Seeing is believing. Patients shown proof of calcification adhered better to statins; those without CAC avoided overtreatment ...

The US Food and Drug Administration (FDA) has granted clearance to Caristo Diagnostics for CaRi-Plaque, an AI-assisted ...

When coronary computed tomography angiography (CCTA) was introduced, it marked a major advancement with its ability to provide anatomical assessment of the arteries for plaque burden. CCTA is a ...

Elucid, an AI medical technology company focused on providing physicians with a more precise view of atherosclerosis to drive patient-specific therape ...

Australia: A recent randomized clinical trial has highlighted the potential benefits of integrating coronary artery calcium ...

Stamford, Connecticut Wednesday, March 12, 2025, 15:00 Hrs [IST] ...

Specifically, coronary artery plaques causing moderate (≥50%) to severe (≥70%) luminal stenosis by CCTA were associated with higher incident mortality risk compared to less critical plaques ...

Technologies like Heartflow fractional flow reserve computed tomography (FFR CT) provide lesion-specific physiology, which enhances CCTA’s diagnostic accuracy. Now Heartflow Plaque Analysis ...

The CaRi-Plaque technology supports non-invasive analysis of coronary anatomy and pathology from routine coronary computed ...

The software quantifies coronary inflammation and arterial plaque build-up based on routine coronary computed tomography angiography (CCTA) scans. CAD was responsible for around 370,000 deaths ...

and distribution. However, an abundance of additional data can be gleaned from CCTA, including plaque composition, overall coronary artery plaque burden, left ventricular function, segmental wall ...